Brewin Dolphin Wealth Management LTD Neurocrine Biosciences Inc Transaction History

Brewin Dolphin Wealth Management LTD

  • $917 Million
  • Q2 2022

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2020

Nov 09, 2023
SELL
$75.11 - $113.76 $8,637 - $13,082
-115 Closed
0 $0
Q4 2019

Nov 09, 2023
BUY
$86.8 - $118.57 $9,982 - $13,635
115 New
115 $12.4 Million

Others Institutions Holding NBIX

# of Institutions
628
Shares Held
94.4M
Call Options Held
505K
Put Options Held
343K
View Full List

About NEUROCRINE BIOSCIENCES INC

NBIX Quotes by TradingView
  • Ticker NBIX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 95,639,296
  • Market Cap $13.2B
  • Description
  • Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...
More about NBIX
Track This Portfolio

Track Brewin Dolphin Wealth Management LTD Portfolio

Follow Brewin Dolphin Wealth Management LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Brewin Dolphin Wealth Management LTD, based on Form 13F filings with the SEC.

News

Stay updated on Brewin Dolphin Wealth Management LTD with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email